CAMBRIDGE, MA -— GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic, imaging and other biomedical data in research and clinical care, today announced the appointment of Michelle Munson, CEO of Aspera, an IBM Company, to its board as an independent director. “We […]
BILLERICA, Mass. —- RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Scott R. Bortner, Ph.D., J.D., as its new Vice President of Intellectual Property. Dr. Bortner will be responsible for strengthening and defending the IP portfolio underlying the company’s core digital droplet technology and […]
COLUMBUS, Ohio –– GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today the launch of its innovative SaaS developed to deliver to the market a next-generation sequencing (NGS) analysis engine that provides an unprecedented combination of performance, quality, cost and scale, eliminating the investment in high-performance computing resources and specialized personnel. […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the MiSeq FGx Forensic Genomics System, the first fully validated forensic next-generation sequencing (NGS) system, which simultaneously interrogates short tandem repeats (STR) and other valuable genetic markers, including single nucleotide polymorphisms (SNPs), to provide informative DNA profiles. The system enables more robust analysis […]
ST. LOUIS — — Partek Incorporated announces the newest release of their popular analysis software, Partek Flow 4.0. With new features including multi-factor mixed model ANOVA, Fisher’s exact test, and additional visualizations, Partek Flow is an ideal analysis solution for researchers performing next generation sequencing (NGS) based studies. Using any internet connected computer, tablet, or […]
SANTA CLARA, Calif.– Technologies Inc. (NYSE: A) today announced it has named Alacris Theranostics, a Berlin-based company active in the area of next-generation sequencing (NGS)-driven personalized medicine, as an Agilent Certified Service Provider for target enrichment. Agilent certifies select laboratories that leverage the company’s market-leading technologies to provide analysis services of the highest quality. Hands-on […]
PROVIDENCE, R.I. and PARIS — Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in oncology, and Ariana Pharmaceuticals SA, a developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, today announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and […]
ALAMEDA, Calif. -– LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect, a powerful, yet easy-to-use application for prioritizing gene variants resulting from next generation sequencing (“NGS”) experiments. VarElect rapidly prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in […]
CARLSBAD, Calif. — The newly released CE-IVD Oncomine Solid Tumor DNA kit from Thermo Fisher Scientific enables highly accurate and reliable multiplexed sequencing of formalin-fixed, paraffin embedded (FFPE) tumor samples with the quality and performance needed for the clinical laboratory. Compared to other molecular diagnostic testing methods, such as qPCR or Sanger sequencing, next-generation sequencing […]
CARLSBAD, Calif. — Thermo Fisher Scientific today announced it has signed an agreement with Cynvenio Biosystems Inc., a molecular testing company focused on the genomic analysis of tumor biomarkers in the bloodstream, for rights to distribute its LiquidBiopsy platform. The addition of Cynvenio’s rare cell enrichment technology complements Thermo Fisher’s Ion Torrent Personal Genome Machine […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
